SG Americas Securities’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,552
Closed -$28K 3006
2025
Q1
$28K Sell
1,552
-397
-20% -$11.3K ﹤0.01% 3346
2024
Q4
$72K Buy
1,949
+539
+38% +$20.6K ﹤0.01% 2830
2024
Q3
$45K Buy
+1,410
New +$78.3K ﹤0.01% 3265
2024
Q2
Sell
-1,001
Closed -$145K 2905
2024
Q1
$145K Sell
1,001
-1,145
-53% -$96.7K ﹤0.01% 2234
2023
Q4
$198K Buy
2,146
+548
+34% +$55.7K ﹤0.01% 2176
2023
Q3
$264K Buy
+1,598
New +$208K ﹤0.01% 2150
2023
Q2
Sell
-3,082
Closed -$105K 2395
2023
Q1
$105K Buy
3,082
+10
+0.3% +$522 ﹤0.01% 2871
2022
Q4
$178K Buy
3,072
+1,102
+56% +$68.1K ﹤0.01% 2284
2022
Q3
$185K Sell
1,970
-4,914
-71% -$699K ﹤0.01% 2391
2022
Q2
$1.54M Buy
6,884
+5,019
+269% +$1.68M 0.02% 925
2022
Q1
$1.02M Buy
1,865
+425
+30% +$257K 0.01% 1407
2021
Q4
$952K Buy
1,440
+260
+22% +$199K 0.01% 1687
2021
Q3
$990K Buy
1,180
+1,042
+755% +$1.06M ﹤0.01% 1916
2021
Q2
$175K Sell
138
-358
-72% -$404K ﹤0.01% 2399
2021
Q1
$544K Buy
496
+318
+179% +$420K ﹤0.01% 1970
2020
Q4
$255K Buy
+178
New +$190K ﹤0.01% 2480
2020
Q3
Sell
-252
Closed -$176K 2789
2020
Q2
$176K Buy
+252
New +$146K ﹤0.01% 2960
2020
Q1
Sell
-176
Closed -$110K 3454
2019
Q4
$110K Buy
+176
New +$86.1K ﹤0.01% 2896
2019
Q2
Sell
-6,128
Closed -$1.01M 3113
2019
Q1
$1.01M Buy
6,128
+140
+2% +$22.8K 0.01% 1276
2018
Q4
$648K Sell
5,988
-7
-0.1% -$1.18K 0.01% 1676
2018
Q3
$1.5M Buy
+5,995
New +$1.29M 0.01% 1386

Other funds holding CDLX

SG Americas Securities's CDLX Position: Q2 2025 in Review

SG Americas Securities sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 1,552 shares — an estimated $28K sold.

SG Americas Securities first reported a position in CDLX in Q3 2018 and held it in 21 quarters. The position peaked at $1.54M in Q2 2022. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • SG Americas Securities reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • SG Americas Securities sold 1,552 Cardlytics shares in Q2 2025, an estimated $28K.
  • SG Americas Securities first reported a position in Cardlytics in Q3 2018 and held it in 21 quarters.
  • SG Americas Securities's Cardlytics position peaked at $1.54M in Q2 2022.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.